- Supported exchanges /
- TW /
- 4142.TW
Adimmune Corp (4142 TW) stock market data APIs
Adimmune Corporation engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; and purified Tuberculin, as well as contract manufacturing services. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was incorporated in 1965 and is headquartered in Taichung, Taiwan.
Adimmune Corp Financial Data Overview
| 22.2 | |
| 22.35 | |
| - | |
| 22.5 | |
| 22.2 | |
| 21.6-36.6 | |
| 9 357 M | |
| 422 M | |
| 1 657 M | |
| 0.459 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Adimmune Corp Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 657 M
- EBITDA -481 340 000
- Earnings Per Share -1.44
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Adimmune Corp Earnings via APIs
- Latest Release 2024-11-12
- EPS/Forecast NaN
Get Adimmune Corp End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
